<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Tran TTT</submitter><funding>Association for Progressive Communications</funding><funding>Science Foundation Ireland</funding><funding>Food Institutional Research Measure</funding><funding>Department of Agriculture, Food and the Marine, Ireland</funding><funding>Sugar Research Australia</funding><funding>Biotechnology and Biological Sciences Research Council</funding><pagination>8221-8231</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6593891</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>33(7)</volume><pubmed_abstract>Apolipoprotein E (&lt;i>APOE&lt;/i>) genotype is the strongest prevalent genetic risk factor for Alzheimer's disease (AD). Numerous studies have provided insights into the pathologic mechanisms. However, a comprehensive understanding of the impact of &lt;i>APOE&lt;/i> genotype on microflora speciation and metabolism is completely lacking. In this study, we investigated the association between &lt;i>APOE&lt;/i> genotype and the gut microbiome composition in human and &lt;i>APOE&lt;/i>-targeted replacement (TR) transgenic mice. Fecal microbiota amplicon sequencing from matched individuals with different &lt;i>APOE&lt;/i> genotypes revealed no significant differences in overall microbiota diversity in group-aggregated human &lt;i>APOE&lt;/i> genotypes. However, several bacterial taxa showed significantly different relative abun</pubmed_abstract><journal>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</journal><pubmed_title>&amp;lt;i&amp;gt;APOE&amp;lt;/i&amp;gt; genotype influences the gut microbiome structure and function in humans and mice: relevance for Alzheimer's disease pathophysiology.</pubmed_title><pmcid>PMC6593891</pmcid><funding_grant_id>BBS/E/F/000PR10353</funding_grant_id><funding_grant_id>PRJNA533610</funding_grant_id><funding_grant_id>BBS/E/F/000PR10356</funding_grant_id><funding_grant_id>BBS/E/F/00044453</funding_grant_id><funding_grant_id>BB/M004449/1</funding_grant_id><pubmed_authors>Corsini S</pubmed_authors><pubmed_authors>Tran TTT</pubmed_authors><pubmed_authors>Muller M</pubmed_authors><pubmed_authors>Minihane AM</pubmed_authors><pubmed_authors>Narbad A</pubmed_authors><pubmed_authors>O'Toole PW</pubmed_authors><pubmed_authors>Tejera N</pubmed_authors><pubmed_authors>Le Gall G</pubmed_authors><pubmed_authors>Hegarty C</pubmed_authors><pubmed_authors>Vauzour D</pubmed_authors><pubmed_authors>Kellingray L</pubmed_authors></additional><is_claimable>false</is_claimable><name>&amp;lt;i&amp;gt;APOE&amp;lt;/i&amp;gt; genotype influences the gut microbiome structure and function in humans and mice: relevance for Alzheimer's disease pathophysiology.</name><description>Apolipoprotein E (&lt;i>APOE&lt;/i>) genotype is the strongest prevalent genetic risk factor for Alzheimer's disease (AD). Numerous studies have provided insights into the pathologic mechanisms. However, a comprehensive understanding of the impact of &lt;i>APOE&lt;/i> genotype on microflora speciation and metabolism is completely lacking. In this study, we investigated the association between &lt;i>APOE&lt;/i> genotype and the gut microbiome composition in human and &lt;i>APOE&lt;/i>-targeted replacement (TR) transgenic mice. Fecal microbiota amplicon sequencing from matched individuals with different &lt;i>APOE&lt;/i> genotypes revealed no significant differences in overall microbiota diversity in group-aggregated human &lt;i>APOE&lt;/i> genotypes. However, several bacterial taxa showed significantly different relative abun</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Jul</publication><modification>2026-05-07T06:16:53.193Z</modification><creation>2019-07-24T07:29:06Z</creation></dates><accession>S-EPMC6593891</accession><cross_references><pubmed>30958695</pubmed><doi>10.1096/fj.201900071R</doi></cross_references></HashMap>